![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1254 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Reymond, Sophie (Sophia Genetics 202002 Media RElations Specialist) | Public Relations Manager / Investor Relations Manager | Sophia Genetics (Group) | Région Lémanique (region) |
| Ricci, Paolo | n. a. | Merck (DE) (Group) | Région Lémanique (region) |
| Ridinger, Richard (Lonza 201205–201902 CEO before Cognis 11 years + Henkel 14 years RETIRED 3/19) | Chief Executive Officer (CEO) | Lonza (Group) | Northwestern Switzerland (region) |
| Ries, Stefan (Disco Pharmaceuticals 202401– CSO before Roche + Versant Ventures) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Disco Pharmaceuticals (Group) | Nordrhein-Westfalen (federal state) |
| Rigby, Peter (Informa 1988–201312 CEO joined 1983 retired 12/13) | Chief Executive Officer (CEO) | Informa (Group) [NEW] | Central Switzerland (region) |
| Riley, Jeffrey (Gain Therapeutics 201909– Independent Board Director formerly SKB + Pfizer + Queensland Biocapital Fund) | Board member, non-executive | Gain Therapeutics (Group) | Ticino (region) |
| Riley, Nicole (ADC Therapeutics 202307 Media Relations) | Public Relations Manager / Investor Relations Manager | ADC Therapeutics (Group) | Région Lémanique (region) |
| Riley, Ray (Syngenta Seeds 200705 Head Product Development) | Research & Development Manager | Syngenta (Group) | Northwestern Switzerland (region) |
| Rinner, Oliver (Biognosys 202109 CEO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bruker (Group) | Zürich (region) |
| Rinsch, Chris (Amazentis 202209 CEO + Co-Founder) | Chief Executive Officer (CEO) | Amazentis S.A. | Région Lémanique (region) |
| Rizzoli, Giancarlo (4D Lifetec 202310 CEO) | Chief Executive Officer (CEO) | 4D Lifetec AG | Central Switzerland (region) |
| Roberts, Christopher (Chris) (AC Immune 202401– promoted to CFO joined 2019) | Chief Financial Officer (CFO) | AC Immune S.A. (Nasdaq: ACIU) | Région Lémanique (region) |
| Rocci, Mario (Solvias 202203 Chair + Advisor Water Street Healthcare Partners) | Board member, non-executive | Solvias (Group) | Northwestern Switzerland (region) |
| Rochat, Bertrand (Univ Lausanne 201410 CHUV) | n. a. | University of Lausanne (UNIL) | Région Lémanique (region) |
| Rocher, Jean-Philippe (Addex 201802– Co-Head Disovery before Pierre Fabre + Addex + Devgen + GSK Japan + Batelle) | management (personnel) | Addex (Group) | Région Lémanique (region) |
| Rohde, Hans Christian (Uniqure 201212–201508 CCO RETIRED 8/15 before GSK/Stiefel + Basilea + Merck Serono) | Chief Commercial Officer (CCO) | Uniqure (Group) | North Holland (province, NL) |
| Rolin, Eric (PregLem SA 200606– CFO before consultant before Warner-Lambert Co) | Chief Financial Officer (CFO) | Gedeon Richter (Group) | Région Lémanique (region) |
| Romero, Yannick (Saphetor SA 201601– Head Business Development) | Business Development Manager / Strategy Manager | Saphetor S.A. (VarSome) | Région Lémanique (region) |
| Rommel, Christian (Bayer 202102– Head RnD of Pharma division before Roche + Amgen + Intellikine + Merck Serono) | President/Director/Head Business Group/Unit/Division | Bayer (Group) | Germany (state/region unspecified) |
| Rosat, Jean-Pierre (Aleva Neurotherapeutics 201108 CEO) | Chief Executive Officer (CEO) | Aleva Neurotherapeutics S.A. | Région Lémanique (region) |
| Roscigno, Giorgio (FIND 200601 CEO) | Chief Executive Officer (CEO) | FIND – Foundation for Innovative New Diagnostics | Région Lémanique (region) |
| Rosén, Christer (EffRx 201009 CEO) | Chief Executive Officer (CEO) | EffRx Pharmaceuticals S.A. | Zürich (region) |
| Rosenberg, Tony (MPM Capital 201711 Managing Director before Novartis + Sandoz) | Managing Director | MPM Capital (Group) | Massachusetts (federal state) |
| Rothman, Dan (Roivant 201910 Chief Information Officer) | Chief Information Officer (CIO) / Chief Digital Officer | Roivant (Group) | Northwestern Switzerland (region) |
| Roy, Subhasis (Novaremed 201808 COO) | Chief Operating Officer (COO) | Novaramed AG | Northwestern Switzerland (region) |
| Rudischhauser, Doris (Dynamics Group 202208 Consultant Crisis Communication) | Public Relations Manager / Investor Relations Manager | Dynamics Group AG | Zürich (region) |
| Rueega, Priska (GlycArt CFO) | Chief Financial Officer (CFO) | Roche (Group) | Zürich (region) |
| Rufenacht, Daniel (SGS 202012 Group VP Corporate Communciations + Sustainability) | Public Relations Manager / Investor Relations Manager | SGS (Group) | Région Lémanique (region) |
| Ruffieux, Pierre-Alain (Lonza 202011– CEO before Roche + Novartis + Serono) | Chief Executive Officer (CEO) | Lonza (Group) | Northwestern Switzerland (region) |
| Rummelt, Andreas (InterPharmaLink 202011 CEO + Partner before Novartis + Sandoz) | Chief Executive Officer (CEO) | InterPharmaLink AG | Northwestern Switzerland (region) |
| Rupalla, Katrin (Ymmunobio 202206 CEO) | Chief Executive Officer (CEO) | Ymmunobio AG | Northwestern Switzerland (region) |
| Russell, Simon (Creabilis 201205– CBO before Novartis Pharma AG + AstraZeneca + ICI Pharmaceuticals) | Chief Business Officer (CBO) | Creabilis (Group) | Luxembourg (cl=4) |
| Ryan, J. Michael (Asceneuron 201704 CMO) | Chief Medical Officer (CMO) | Asceneuron S.A. | Région Lémanique (region) |
| Rüegg, André (Bellevue Group 201409 CEO of Bellevue Asset Management) | Chief Executive Officer (CEO) | Bellevue (Group) | Zürich (region) |
| Rüsch, Jacqueline Ruedin (Privilège Ventures 202209 Founding General Partner) | General Partner (venture partner) | Privilège Ventures (CH) | Ticino (region) |
| Rüttinger, Dominik (Bayer 202110– Head of Research + Early Development for Oncology before Roche pRED + Micromet) | Research & Development Manager | Bayer (Group) | Germany (state/region unspecified) |
| Röll, Marcel (Wave Biotech AG 200605 CEO) | Chief Executive Officer (CEO) | Sartorius (Group) | Zürich (region) |
| Röver, Stephan (Roche 201006 Scientific Expert for Discovery Chemistry) | Researcher (industry) | Roche (Group) | Northwestern Switzerland (region) |
| Sabry, James H. (Roche 201808– Global Head Partnering joined Genentech 2010 before Arete Therapeutics + Cytokinetics) | Business Development Manager / Strategy Manager | Roche (Group) | Northwestern Switzerland (region) |
| Sack, Stephan (Harlan Laboratories 200910 Manager Analytical Services at Harlan Laboratories Ltd) | Laboratory Manager (industry) | Envigo (Group) | Northwestern Switzerland (region) |
| Sager, Cédric (Debiopharm 201403 CEO of Debiopharm Research & Manufacturing SA) | Chief Executive Officer (CEO) | Debiopharm (Group) | Région Lémanique (region) |
| Said, Maya (Transgene 201706– Non-Executive Board Member before Novartis + Sanofi + Boston Consulting) | Board member, non-executive | Mérieux (Group) | Grand Est (Great East) (region) |
| Salzmann, Michael (Neurimmune 2008– COO + General Manager before Bruker + Roche + ETH Zürich) | Chief Operating Officer (COO) | Neurimmune AG | Zürich (region) |
| Sanchez, Jean-Charles (Univ Geneva 201204 Professor + Director Biomedical Proteomics Research Group) | Professor | University of Geneva (Université de Genève, UNIGE) | Région Lémanique (region) |
| Sandor, Victor (ADC Therapeutics 202004– Board Director before CMO at Array BioPharma + Incyte + Biogen Idec + AZ) | Board member, non-executive | ADC Therapeutics (Group) | Région Lémanique (region) |
| Sansawat, Supreeya (SGS 201012 Global Manager of Food Services) | n. a. | SGS (Group) | Région Lémanique (region) |
| Santagostino, Alberto (Lonza 201906 SVP Head of Cell + Gene Technologies at Lonza Pharma + Biotech) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
| Santarelli, Luca (VectivBio 202001– CEO before Therachon CEO + Roche 201110 Global Head Neuroscience Translational Area) | Research & Development Manager | Ironwood (Group) | Northwestern Switzerland (region) |
| Santos da Silva, Jorge P. (MoonLake 202107– CEO before nearly 15 years at McKinsey) | Consultant (economic/technology) | MoonLake Immunotherapeutics AG | Central Switzerland (region) |
| Sauer, Dirk (Novartis 202012 Head of Ophthalmology Franchise at Novartis Pharma AG( | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Northwestern Switzerland (region) |
| Sauer, Uwe (ETH Zurich 201007 Institute of Molecular Systems Biology) | Researcher (university / research institute) | ETH Zürich (ETHZ) | Zürich (region) |
| Savitzky, Rodolfo (Lonza 201801 CFO) | Chief Financial Officer (CFO) | Lonza (Group) | Northwestern Switzerland (region) |
| Schaffert, Susanne (Novartis 201901–2022 CEO of Oncology Business Unit joined Novartis >20 years ago RETIRED 2022) | Chief Executive Officer (CEO) | Novartis (Group) | Northwestern Switzerland (region) |
| Schaub, Christian (Redbiotec 201501 CEO) | Chief Executive Officer (CEO) | Redbiotec AG | Zürich (region) |
| Schefold, Christian (Dentons 201501– Counsel before Counsel at Daimler + Daimler Financial Services) | Attorney / Lawyer | Dentons (Group) | Switzerland_other |
| Scheidegger, Alfred (Nextech Invest 201104 CEO + Founding Partner) | Chief Executive Officer (CEO) | Nextech (Group) | Zürich (region) |
| Scherer, Dieter (Novaliq GmbH 200904– CBO before Apis Pharma + SKyePharma CH + LTS Lohmann) | Chief Business Officer (CBO) | HOPP Group (family of Dietmar Hopp) | Baden-Württemberg (federal state) |
| Scherer, Stefan J. (3T Biosciences 202301 formerly Biocartis + Roche/Genentech + Grünenthal) | Chief Executive Officer (CEO) | 3T Biosciences Inc. | California (federal state) |
| Scherrer, Frank (Wenger & Vieli 200809 Zurich) | n. a. | Wenger & Vieli Attorneys at Law (Zurich) | Zürich (region) |
| Scherz, Michael, Ph.D. (Metys Pharmaceuticals 201304– CEO + Co-Founder before Actelion 2000–2012 + P&G Pharma) | Chief Executive Officer (CEO) | Metys Pharmaceuticals AG | Northwestern Switzerland (region) |
| Schier, Eva (AC Immune 201605 Corporate Communciations Manager) | public relations / investor relations | AC Immune S.A. (Nasdaq: ACIU) | Région Lémanique (region) |
| Schier, Robert (Zürcher Kantonalbank 201909 Investment Director PE/V Health-Tech at Swisscanto Invest) | Investment Manager | Zürcher Kantonalbank (ZKB) | Switzerland_other |
| Schiersing, Monique (Roche 201510 Roche Venture Fund) | Investment Manager | Roche (Group) | Northwestern Switzerland (region) |
| Schiess, Ralph (Proteomedix 202001 CSO + Co-Founder before CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Proteomedix AG | Zürich (region) |
| Schill Schulze, Natascha (Neurimmune 201811– VP Project + Alliance Management before 22 years at Biogen) | Business Development Manager / Strategy Manager | Neurimmune AG | Zürich (region) |
| Schilling, Guido (Axis-Shield 2008– Managing Director of newly acquired Axis-Shield AG before Nycomed AG Marketing Man) | Managing Director | Abbott (Group) | Zürich (region) |
| Schimkat, Dirk (Neurimmune 201104 CFO before Beiersdorf before Univ Basel) | Chief Financial Officer (CFO) | Neurimmune AG | Zürich (region) |
| Schindler, Stephan (Bachem 201203 CFO) | Chief Financial Officer (CFO) | Bachem (Group) | Northwestern Switzerland (region) |
| Schlapbach, Jakob (Delenex 201012– CFO before 10y+ Cytos Biotechnology CFO before Ascom CFO) | Chief Financial Officer (CFO) | Athenex (Group) | Zürich (region) |
| Schläpfer, Rolf (Roche 199701–200812 Head of Corporate Communication) | n. a. | Roche (Group) | Northwestern Switzerland (region) |
| Schlösser, Beate (Endress+Hauser 201705 Assitant Public + Internal Communication) | Public Relations Manager / Investor Relations Manager | Endress+Hauser (Group) | Northwestern Switzerland (region) |
| Schmid, Frederick (Panacos 200605 Senior VP BusDev before Roche before GSK) | Business Development Manager / Strategy Manager | Panacos Pharmaceuticals Inc. (Nasdaq: PANC) | Massachusetts (federal state) |
| Schmid, Michael (Genexa 2018– Founder) | Company Founder | Genexa AG | Zürich (region) |
| Schmidheini, Tobias (Microsynth 200804 CEO) | Chief Executive Officer (CEO) | Microsynth (Group) | Eastern Switzerland (region) |
| Schmidt, Timo (EffRx Pharmaceuticals 201310 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | EffRx Pharmaceuticals S.A. | Zürich (region) |
| Schmitz, Alexander (Endeavour Vision 201605) | Investment Manager | Endeavour Vision (Group) | Région Lémanique (region) |
| Schneckenburger, Thomas (Molecular Partners 202010 PR + Evolva 202112 Investor + Corporate Relations) | Public Relations Manager / Investor Relations Manager | Lallemand (Group) | Northwestern Switzerland (region) |
| Schnee, Elmar (Cardiorentis 201110– CEO before Merck Serono S.A. 200701 CEO before Merck KGaA) | Chief Executive Officer (CEO) | Cardiorentis (Group) | Central Switzerland (region) |
| Schnell, Beate (InSphero 201601– Head of Sales before Promega + Abbott Diagnostics) | Sales Manager / Marketing Manager | InSphero (Group) | Zürich (region) |
| Schoch, Daniel (Zürcher Kantonalbank 201808 Head of Start-up FInance) | Investment Manager | Zürcher Kantonalbank (ZKB) | Zürich (region) |
| Schofield, Desmond (Evitria 202107 Director of Business Development) | Business Development Manager / Strategy Manager | Atlas Antibodies (Group) | Zürich (region) |
| Schollmeier, Klaus (SuppreMol 201304– Managing Director before Santhera CEO + ING BHF-Bank + Abbott/Knoll/BASF) | Managing Director | Baxter (Group) | Bayern (federal state) |
| Scholz, Bernhard (Xlife Sciences 202201 Board Chair) | Board member, non-executive | Xlife Sciences AG (SIX: XLS) | Zürich (region) |
| Schorsch, Susanne K. (Verve Ventures 202204 Venture Investor before BASF) | Investment Manager | Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) | Central Switzerland (region) |
| Schreiner, Claudia (Univ Zurich 201301 Dept of Geography) | n. a. | University of Zurich (UZH) | Zürich (region) |
| Schrems, Angelika (Bionter 202305 Global Head of Business Development) | Business Development Manager / Strategy Manager | Bionter AG | Northwestern Switzerland (region) |
| Schroff, Matthias (Vaximm 201609– CEO before Mologen CEO) | Chief Executive Officer (CEO) | Vaximm (Group) | Northwestern Switzerland (region) |
| Schropp, Katharina (Informa 201812 EBD Group) | Managing Director | Informa (Group) [NEW] | Central Switzerland (region) |
| Schröder, Peer Nils (Basilea 201109 Head Public Relations + Corporate Communications) | Public Relations Manager / Investor Relations Manager | Basilea (Group) | Northwestern Switzerland (region) |
| Schröder, Thilo (Nextech Invest 201607 Partner) | Partner (venture partner) | Nextech (Group) | Zürich (region) |
| Schule, Marylin Mermod (Sophia Genetics 201801– COO joined 201506 as CFO before Benjamin de Rothschild + La Metairie) | Chief Financial Officer (CFO) | Sophia Genetics (Group) | Région Lémanique (region) |
| Schultheiss, Luc (Endress+Hauser 201309 CFO) | Chief Financial Officer (CFO) | Endress+Hauser (Group) | Northwestern Switzerland (region) |
| Schulze, Andreas J. (Dualsystems Biotech 201306 CEO before CBO before DEWB + Epidauros Interim CEO + Board) | Chief Executive Officer (CEO) | Dualsystems Biotech (Group) | Zürich (region) |
| Schulze, Stefan (Vifor Pharma 201911 COO + President of Executive Committee) | Chief Operating Officer (COO) | Vifor Pharma (Group) | Zürich (region) |
| Schumacher, Karl (Tolremo Therapeutics 202206– CMO before Merck KGaA) | Chief Medical Officer (CMO) | Tolremo Therapeutics AG | Northwestern Switzerland (region) |
| Schutte, Eliane (Xeltis 202005 CEO) | Chief Executive Officer (CEO) | Xeltis (Group) | Zürich (region) |
| Schwab, Martin E. (NovaGo Therapeutics 201903 President + Founder) | President/Director/Head Business Group/Unit/Division | NovaGo Therapeutics AG | Zürich (region) |
| Schwan, Severin (Roche 2008 CEO before CEO of division Roche Diagnostics) | Chief Executive Officer (CEO) | Roche (Group) | Northwestern Switzerland (region) |
| Schwarz, Otto (Actelion 201106– COO before Head Business Strategy + Operations since 2008) | Chief Operating Officer (COO) | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
| Schweiger, Christian (Shield Therapeutics 2008– CSO + Co-founder before Encysive Pharmaceuticals before Actelion) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Iron Therapeutics (Switzerland) AG | Central Switzerland (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
